New 6-year data for Roche’s OCREVUS (ocrelizumab) show earlier treatment initiation nearly halves risk of needing walking aid in relapsing multiple sclerosis

Frank Burrell
Scientific Storytelling

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Matt Turner
Patient Affordability

Liz Kane
Impactful Strategy

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Suma Ramadas, PhD
Medical Affairs

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement